glp-1 antagonist drugs Holding Agonists Prior to Elective Procedures List of approved and pending
Description
Semaglutide was approved in 2017 as Ozempic for diabetes, and in 2021 as Wegovy for obesity
Supports overall daily wellness
Discover the transformative impact of GLP-1 agonists, originally a diabetes treatment, on thousands of peoples weight-loss journey.
Given the potential for increased INR variability, clinicians may consider increasing INR monitoring frequency following GLP-1 RA initiation.
Find out everything about this - if its true and worth all the hype.
No matter how hard you try, they keep coming back
